Royal Bank Of Canada Atea Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 10,128 shares of AVIR stock, worth $34,131. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,128

Previous 7,257 39.56%

Holding current value

$34,131

Previous $24,000 37.5%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.17 - $4.02 $9,101 - $11,541	2,871 Added 39.56%	10,128 $33,000
Q2 2024 Aug 14, 2024	BUY	$3.31 - $4.04 $13,527 - $16,511	4,087 Added 128.93%	7,257 $24,000
Q1 2024 Nov 05, 2024	SELL	$3.09 - $4.56 $12,628 - $18,636	-4,087 Reduced 56.32%	3,170 $12,000
Q1 2024 May 15, 2024	SELL	$3.09 - $4.56 $81,696 - $120,561	-26,439 Reduced 89.29%	3,170 $12,000
Q4 2023 Feb 14, 2024	BUY	$2.8 - $3.35 $43,638 - $52,209	15,585 Added 111.13%	29,609 $90,000
Q3 2023 Nov 14, 2023	BUY	$3.0 - $3.79 $18,078 - $22,838	6,026 Added 75.34%	14,024 $42,000
Q2 2023 Aug 14, 2023	BUY	$3.21 - $5.06 $7,139 - $11,253	2,224 Added 38.52%	7,998 $29,000
Q1 2023 May 15, 2023	SELL	$3.0 - $4.97 $14,670 - $24,303	-4,890 Reduced 45.86%	5,774 $19,000
Q4 2022 Feb 14, 2023	BUY	$4.35 - $6.17 $26,656 - $37,809	6,128 Added 135.1%	10,664 $51,000
Q3 2022 Nov 14, 2022	BUY	$5.49 - $8.79 $13,763 - $22,036	2,507 Added 123.56%	4,536 $26,000
Q2 2022 Aug 15, 2022	SELL	$5.33 - $8.18 $18,862 - $28,949	-3,539 Reduced 63.56%	2,029 $15,000
Q1 2022 May 16, 2022	SELL	$5.5 - $9.19 $31,245 - $52,208	-5,681 Reduced 50.5%	5,568 $41,000
Q4 2021 Feb 14, 2022	BUY	$7.67 - $44.59 $23,025 - $133,859	3,002 Added 36.4%	11,249 $100,000
Q3 2021 Nov 15, 2021	BUY	$21.33 - $35.06 $44,579 - $73,275	2,090 Added 33.95%	8,247 $290,000
Q2 2021 Aug 16, 2021	BUY	$19.22 - $59.08 $118,337 - $363,755	6,157 New	6,157 $133,000

Others Institutions Holding AVIR

# of Institutions

112

Shares Held

52.4M

Call Options Held

900

Put Options Held

126K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $281M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Atea Pharmaceuticals, Inc. Transaction History